CGTX•benzinga•
B. Riley Securities Upgrades Cognition Therapeutics to Buy, Raises Price Target to $1.5
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 19, 2024 by benzinga